Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 13

A Variant of Leptin Gene Decreases the Risk of Gastric Cancer in Chinese Individuals: Evidence from a Case–Control Study [Corrigendum]

Authors Ma R, He Q

Received 5 October 2020

Accepted for publication 5 October 2020

Published 14 October 2020 Volume 2020:13 Pages 485—486

DOI https://doi.org/10.2147/PGPM.S285321


Ma R, He Q. Pharmgenomics Pers Med. 2020;13:397–404.

The authors have advised the affiliation list on page 397 is incorrect. The correct author list and affiliation is as follows.

Renjie Ma1
Qi He2

1Department of General Surgery, The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, 212300, Jiangsu Province, China; 2Department of Infectious Disease, The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, 212300, Jiangsu Province, China


Read the original article
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]